128 related articles for article (PubMed ID: 33579528)
1. Sociodemographic predictors associated with the spectrum of non-opportunist neuroretinal disease of non-infectious etiology in patients with HIV/AIDS: a scoping review.
Gómez-Gualdrón SA; Sánchez-Uzcátegui MA; Camacho-López PA
Arch Soc Esp Oftalmol (Engl Ed); 2021 Feb; ():. PubMed ID: 33579528
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic predictors associated with the spectrum of non-opportunist neuroretinal disease of non-infectious etiology in patients with HIV/AIDS: A scoping review.
Gómez-Gualdrón SA; Sánchez-Uzcátegui MA; Camacho-López PA
Arch Soc Esp Oftalmol (Engl Ed); 2022 May; 97(5):251-263. PubMed ID: 35526949
[TBL] [Abstract][Full Text] [Related]
3. Neuroretinal Degeneration in HIV Patients Without Opportunistic Ocular Infections in the cART Era.
Demirkaya N; Wit F; Schlingemann R; Verbraak F
AIDS Patient Care STDS; 2015 Oct; 29(10):519-32. PubMed ID: 26258992
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS.
Jabs DA; Drye L; Van Natta ML; Thorne JE; Holland GN;
Ophthalmology; 2015 Apr; 122(4):760-8. PubMed ID: 25600199
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China.
Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH
Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918
[TBL] [Abstract][Full Text] [Related]
7. Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population.
Agarwal A; Singh R; Sharma A; Gupta V; Dogra MR
Ocul Immunol Inflamm; 2017 Jun; 25(3):396-404. PubMed ID: 26910292
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated retinopathy in the HAART era.
Goldberg DE; Smithen LM; Angelilli A; Freeman WR
Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
[TBL] [Abstract][Full Text] [Related]
9. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
10. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for tuberculosis after highly active antiretroviral treatment (HAART) initiation among HIV patients: A systematic review.
Bushra AW; Zeynudin A; Dejene T; Wolde M; Sudhakar M
JBI Libr Syst Rev; 2012; 10(55):3561-3595. PubMed ID: 27819962
[TBL] [Abstract][Full Text] [Related]
13. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Human Immunodeficiency Virus Neuroretinal Disorder and Vision-Specific Quality of Life among People with AIDS.
Ashraf DC; May KP; Holland GN; Van Natta ML; Wu AW; Thorne JE; Jabs DA;
Ophthalmology; 2015 Dec; 122(12):2560-7. PubMed ID: 26350547
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.
Branch AD; Drye LT; Van Natta ML; Sezgin E; Fishman SL; Dieterich DT; Meinert CL; Jabs DA
Clin Infect Dis; 2013 Dec; 57(11):1618-25. PubMed ID: 24081683
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on retinal thickness of the macular region among AIDS patients with normal ocular fundus, HIV-related microvascular retinopathy patients, and cytomegalovirus retinitis patients.
Xie LY; Chen C; Kong WJ; Du KF; Guo CG; Wei WB
Medicine (Baltimore); 2019 Jun; 98(26):e16073. PubMed ID: 31261518
[TBL] [Abstract][Full Text] [Related]
18. [Effects of the introduction of highly active antiretroviral therapy (HAART) on the temporal trend of diagnosis of AIDS and AIDS-defining disorders].
Manfredi R
Infez Med; 2000; 8(3):134-138. PubMed ID: 12711892
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
